We are live on
!
Find out more
JGUA
John G. Ullman & Associates Portfolio holdings
AUM
$754M
1-Year Est. Return
60.05%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$524M
AUM Growth
+$32.8M
(+6.7%)
Cap. Flow
-$6.68M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
32.2%
Holding
157
New
6
Increased
38
Reduced
96
Closed
8
Top Buys
| 1 |
IBM
IBM
|
+$3.58M |
| 2 |
Itron
ITRI
|
+$1.9M |
| 3 |
Eli Lilly
LLY
|
+$1.83M |
| 4 |
Lindsay Corp
LNN
|
+$1.79M |
| 5 |
Emcor
EME
|
+$1.22M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.98M |
| 2 |
ECF
Ellsworth Growth & Income Fund
ECF
|
+$2M |
| 3 |
Archer Daniels Midland
ADM
|
+$1.97M |
| 4 |
Darling Ingredients
DAR
|
+$1.65M |
| 5 |
Invesco Golden Dragon China ETF
PGJ
|
+$1.61M |
Sector Composition
| 1 | Healthcare | 24.97% |
| 2 | Industrials | 17.47% |
| 3 | Technology | 16.95% |
| 4 | Energy | 9% |
| 5 | Utilities | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$595B
| $29.5M | 5.62% |
321,721
+2,625
| +0.8% | +$242K |
|
2
ExxonMobil
XOM
$599B
| $23.6M | 4.5% |
232,934
+7,734
| +3% | +$715K |
|
3
Corning
GLW
$150B
| $22.9M | 4.37% |
1,283,908
-33,078
| -3% | -$545K |
|
4
Emerson Electric
EMR
$76.3B
| $17M | 3.24% |
242,205
+40
| +0% | +$2.67K |
|
5
Coca-Cola
KO
$355B
| $14.1M | 2.69% |
340,982
+8,524
| +3% | +$336K |
|
6
Intel
INTC
$518B
| $13.3M | 2.55% |
514,031
+4,550
| +0.9% | +$110K |
|
|
7
Bristol-Myers Squibb
BMY
$120B
| $13M | 2.47% |
243,722
-58,542
| -19% | -$2.98M |
|
|
PLL
8
DELISTED
PALL CORP
PLL
| $12.9M | 2.45% |
150,611
-7,353
| -5% | -$598K |
|
9
SLB Ltd
SLB
$71.1B
| $11.9M | 2.27% |
131,734
-15,090
| -10% | -$1.36M |
|
10
Merck
MRK
$305B
| $10.7M | 2.04% |
223,417
+12,767
| +6% | +$584K |
|
|
11
IBM
IBM
$199B
| $10.6M | 2.03% |
59,207
+20,779
| +54% | +$3.58M |
|
12
Pfizer
PFE
$141B
| $10.4M | 1.99% |
358,282
-14,365
| -4% | -$418K |
|
13
GSK
GSK
$103B
| $10.2M | 1.94% |
152,285
-2,899
| -2% | -$188K |
|
14
Microsoft
MSFT
$2.94T
| $9.79M | 1.87% |
261,684
-4,300
| -2% | -$156K |
|
|
GXP
15
DELISTED
Great Plains Energy Incorporated
GXP
| $9.75M | 1.86% |
402,200
-35,750
| -8% | -$844K |
|
16
Idacorp
IDA
$8.27B
| $9.46M | 1.81% |
182,475
-2,500
| -1% | -$128K |
|
17
Granite Construction
GVA
$5.45B
| $9.42M | 1.8% |
269,392
+7,700
| +3% | +$242K |
|
18
Honeywell
HON
$70.6B
| $9.13M | 1.74% |
111,244
-3,784
| -3% | -$296K |
|
19
3M
MMM
$83.7B
| $8.87M | 1.69% |
75,655
-1,553
| -2% | -$165K |
|
20
Amgen
AMGN
$193B
| $7.86M | 1.5% |
68,890
-975
| -1% | -$111K |
|
21
BCE
BCE
$20.1B
| $7.56M | 1.44% |
174,599
+10,521
| +6% | +$458K |
|
22
Duke Energy
DUK
$96.9B
| $7.04M | 1.34% |
101,959
-2,873
| -3% | -$201K |
|
23
Novartis
NVS
$288B
| $6.9M | 1.32% |
95,752
-3,180
| -3% | -$221K |
|
24
Analog Devices
ADI
$190B
| $6.26M | 1.2% |
123,016
-3,875
| -3% | -$189K |
|
25
Exelon
EXC
$46.8B
| $6.2M | 1.18% |
317,273
-15,001
| -5% | -$302K |
|
Similar funds
HCM
FSCM
SF
MSWM
RMC
MAM
BEC
AA